GenMont — Annual Report 2021

Sep 16, 2021

==> picture [407 x 54] intentionally omitted <==

==> picture [437 x 64] intentionally omitted <==

GenMont Biotech Incorporation The leading brand of functional probiotics

葉天佑 協理 Alvin Yeh Senior Manager

1

1

益生菌市場前景

==> picture [301 x 9] intentionally omitted <==

Probiotics market outlook

==> picture [15 x 8] intentionally omitted <==

==> picture [16 x 8] intentionally omitted <==

==> picture [16 x 8] intentionally omitted <==

 全球益生菌市場正在快速成長

The global probiotics market is growing rapidly. 其成長的主要原因是消費者對於預防保健的意識提升 The major factor boosting the market growth is increasing concerns of consumers on preventive healthcare.

 中國大陸仍為臺灣食品的重要出口國 China is still an important exporter of Taiwanese food.  後疫情時代來臨，人們更積極尋求維持健康的方法 Beyond the pandemic, people have more conscious about their health and are taking proactive measures to help maintain their well-being. 隨著 COVID-19 疫情蔓延，消費者對機能性食品的長期需求增加 As the COVID-19 pandemic wears on, it increased the long-term demand for functional food/beverages and supplements in the daily behavior of consumers.

資料來源： Functional Food & Beverage 2020 Report Highlights from the Hartman Group

2

全球益生菌市場快速發展

==> picture [469 x 9] intentionally omitted <==

Global probiotics market is growing rapidly

全球市場分析報告顯示， 。 預計 2026 年全球益生菌市場約為 911 億美元

The global market analysis report shows that the global probiotic market is expected to be about 91.1 billion US dollars in 2026.

全球益生菌市場應用 Global probiotics market by product application

Global Probiotics Market

* 市場分布 MARKET SHARE** 功能性食品 Functional food

==> picture [338 x 195] intentionally omitted <==

----- Start of picture text -----

Market forecast to grow at a CAGR of 8.3%
USD 91.1 Billion
USD 61.1 Billion
e-Estimated;
2021-e 2026-p p-Projected
----- End of picture text -----

保健食品與藥品 Health food and medicine 益生菌原料 Probiotics raw material

==> picture [195 x 198] intentionally omitted <==

資料來源：

https://www.reportlinker.com/p05129364/Probiotics-Market-by-Application-Dietary-SupplementsAnimal-Feed-Source-Form-End-User-And-Region-Forecast-to.html?utm_source=GNW; https://www.researchandmarkets.com/reports/5370159/global-probiotics-market-by-application

3

口 中國大陸為臺灣食品重要出 對象

==> picture [638 x 10] intentionally omitted <==

China is an important export target of Taiwanese food

==> picture [353 x 327] intentionally omitted <==

==> picture [104 x 325] intentionally omitted <==

單位 : 新臺幣 ( 億元 ) 出口 1053 億元 占總產值 18.7%

資料來源 : IT IS 智網，食品所 IT IS 團隊分析整理 (2021/06)

4

2021 年度研究成果介紹 The Annual Research Presentation 2021

5

156 項研發專利

Patents over the world

==> picture [701 x 384] intentionally omitted <==

----- Start of picture text -----

日本 JP 澳洲 AU Allergy
9 1 Obesity 治療過敏
8 Cardiac Inflammation
治療肥胖
美國 US 心臟發炎
臺灣 TW Others 3
6
26
50 其他 Autoimmune Diseases
中國 CN H. Pylori 35 自體免疫疾病
29 歐洲 41 EP 抗幽門桿菌 infection Anti-stroke 中風 5 Oral Health
3
4 口腔保健
10
Hypertension
血壓 Picornavirus infection
2 抗腸病毒
3
Blood lipid
Atopic dermatitis
血脂
Wound healing 傷口癒合 3 異位性皮膚炎
& scar care 疤痕護理 6
1 Diabetes
Skin Care 皮膚護理 Psoriasis 糖尿病
3 乾癬 17
4 Weight Control
控制體重
Osteoporosis 骨鬆 4
5
Anti-inflammatory
Pancreatic cancer C. difficile Underarm 抗發炎
胰臟癌 infection Stability odour 10
4 改善
改善困難梭狀 安定性 Vaginal Care 護肝 Liver Care
狐臭
桿菌感染 ( 新型 ) 女性保健 2
4
4 3 7
----- End of picture text -----

6

43 篇文獻發表

Published Papers

==> picture [647 x 410] intentionally omitted <==

----- Start of picture text -----

Safety
Vaginal Care 安全 其他 Others
女性保健 2 2
Skin Care 1
皮膚護理
Allergy
1 過敏
Animal Health 12
動物用益生菌
1
Pancreatic cancer
胰臟癌
2 Asthma
Autoimmune 氣喘
自體免疫疾病
1
4
Anti H. pylori Immunoregulation
抗幽門螺旋桿菌 免疫調節
1 1
Atopic dermatitis
Psoriasis
異位性皮膚炎
乾癬
1
1 Dental health 血糖 Blood sugar
牙齒
3
2 代謝 Metabolism 血脂 Blood lipid
2 6
7
----- End of picture text -----

7

8

==> picture [228 x 207] intentionally omitted <==

==> picture [86 x 54] intentionally omitted <==

==> picture [150 x 29] intentionally omitted <==

==> picture [52 x 73] intentionally omitted <==

==> picture [49 x 73] intentionally omitted <==

==> picture [49 x 72] intentionally omitted <==

==> picture [48 x 71] intentionally omitted <==

==> picture [56 x 73] intentionally omitted <==

==> picture [49 x 71] intentionally omitted <==

==> picture [48 x 71] intentionally omitted <==

==> picture [52 x 70] intentionally omitted <==

TW I 678209B US 10632160 B2 ZL 2018 1 0244949.4 IT 102019000004185 TW I 346554B US 7901926 B2 EP 2287286 B1 ZL 2010 1 0567585.7

==> picture [86 x 58] intentionally omitted <==

==> picture [115 x 139] intentionally omitted <==

==> picture [229 x 120] intentionally omitted <==

==> picture [158 x 141] intentionally omitted <==

運用K-ras[G12D] 基因轉殖小 鼠的胰臟癌動物模式證 實，乳酸桿菌可減弱胰臟 癌惡化

==> picture [299 x 185] intentionally omitted <==

==> picture [85 x 22] intentionally omitted <==

==> picture [197 x 69] intentionally omitted <==

基因轉殖胰臟癌動物模式證 實，乳酸桿菌合併化療藥物 (Gemcitabine)使用，可發揮抑 制癌細胞生長的協同作用

8

NCT04566549

使用時間 : 5 個月 (2020/5 月 -2020/10 月 ) Duration of treatment: 5 months

人數 : 22 人

Estimated Enrollment : 20 participants

起始點 控制組洗髮精 0.5% GMNL[®] -653 洗髮精 before control 0.5% GMNL[®] -653 shampoo 使用時間 time 0 月 0.5 月 1 月 1.5 月 2 月 3 月 5 月 油量 oily ˅ ˅ ˅ ˅ ˅ ˅ ˅ 頭皮屑 dandruff ˅ ˅ ˅ ˅ ˅ ˅ ˅ 髮量 hair volume ˅ ˅ ˅ ˅ 菌相 microbiota ˅ ˅ ˅

==> picture [59 x 149] intentionally omitted <==

9

Financial status 財務狀況

==> picture [185 x 9] intentionally omitted <==

==> picture [237 x 9] intentionally omitted <==

- ※母公司財報 景岳生技 Separate Financial Statements-GenMont

單位：千元 In Thousands of New Taiwan Dollars	107年母公司財報 (Year 107 Single)	108年母公司財報 (Year 108 Single)	109年母公司財報 (Year 109 Single)
營業收入NET REVENUE	406,554	346,244	329,191
營業毛利GROSS PROFIT	277,547	229,701	215,390
營業費用OPERATING EXPENSES	(152,245)	(148,838)	(137,605)
營業利益INCOME(LOSS) FROM OPERATIONS	125,302	80,363	77,785
營業外損益NON- OPERATING INCOME AND EXPENSES	58,522	(5,107)	(269)
稅前淨利INCOME(LOSS) BEFORE INCOME TAX	183,824	75,756	77,516
稅後淨利NET INCOME(LOSS)	158,019	57,451	60,884

10

Financial status 財務狀況

==> picture [185 x 9] intentionally omitted <==

==> picture [237 x 9] intentionally omitted <==

※ 合併財報 Consolidated Financial Statements

單位：千元 In Thousands of New Taiwan Dollars	108年合併 (Year 108 Consolidated)	109年合併 (Year 109 Consolidated)	110年前二季合併 (Year 110 Q2 Consolidated)
營業收入NET REVENUE	346,244	**325,191 **	203,242
營業毛利GROSS PROFIT	229,701	215,390	139,427
營業費用OPERATING EXPENSES	(152,078)	(144,376)	(79,142)
營業利益INCOME(LOSS) FROM OPERATIONS	77,623	71,014	60,285
營業外損益NON-OPERATING INCOME AND EXPENSES	(2,083)	5,833	(2,533)
稅前淨利INCOME(LOSS) BEFORE INCOME TAX	75,540	76,847	57,752
稅後淨利NET INCOME(LOSS)	57,235	60,215	43,819
停業單位損益Income (Loss)from Discountinued Operations	0	0	0
本期淨利NET INCOME(LOSS)	57,235	60,215	43,819

11

Risk Assessment 風險評估

• Financial risk in the biotech sector:

• 生技領域方面財務風險 • 研發期間長 Long R & D period

• 獲利回收晚 Late profit recovery

， 可能因此導致資金不足 Which may lead to insufficient funds 食品生技產業現況 Current Situation of Food Biotechnology Industry 參考 ZION Market Research 數據顯示，中國大陸益生菌產業連續 3 年增長率在 20% 以上，擁有巨大的市場空間。預計到 2025 年，全 。 球益生菌產業的產值將超過 770 億美元，中國市場占比將超過 25% According to data from the ZION Market Research, the probiotics industry in China has grown at over 20% for three consecutive years. Following the growing demand for probiotics, the global probiotics market is projected to reach USD 77 billion by 2025, and the Chinese market will account for more than 25%.

資料來源 : 中國食品報網 2020.08.25 http://www.cnfood.cn/yiqingfangkong163309.html

12

==> picture [257 x 159] intentionally omitted <==

Thanks For Your Attention

==> picture [350 x 99] intentionally omitted <==

----- Start of picture text -----

Q & A
----- End of picture text -----

13